Lando Biomaterials
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Lando Biomaterials - overview
Established
2010
Location
Shenzhen, Guangdong, China
Primary Industry
Materials
About
Established in 2010 and based in Shenzhen, China, Lando Biomaterials operates as a medical materials provider that provides medical treatment and auxiliary materials for injuries and orthopedics. The chairman, president and chief scientist officer of this company, She Zhending, is a PhD from Tsinghua University and was the executive deputy director of the Key Laboratory of Biomedical Materials at Tsinghua University Research Institute in Shenzhen. The company's main business is the research and development of high-end biomedical materials for applications in wound care, oral health, digestive tract, neural/muscular repair, and aesthetic medicine. The company's self-developed products include Lando® double-layer artificial dermis, Lando® oral absorbable biomembrane, and Lando® bone graft materials.
The company generates revenue by providing biomedical materials and solutions.
Current Investors
Leaguer Group, Tsing-Yuan Capital, Albatross Venture
Primary Industry
Materials
Sub Industries
Biotechnology, Therapeutic Devices, Surgical Devices, Medical Supplies, Biomaterials
Website
www.landobiom.com
Verticals
Manufacturing
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.